MOREPENLAB vs LEMONTREE: Stock Comparison

Head-to-head financial and trading comparison between Morepen Laboratories Limited (MOREPENLAB) and Lemon Tree Hotels Limited (LEMONTREE) in the Cross-Sector Peers sector.

MOREPENLAB

NSE: MOREPENLAB
Morepen Laboratories Limited
₹129.55
1Y Return: +213.76%
52W High: ₹146.97
52W Low: ₹41.29
Annual Volatility: 72.31%
Check MOREPENLAB Trade Fees →

LEMONTREE

NSE: LEMONTREE
Lemon Tree Hotels Limited
₹110.43
1Y Return: -2.39%
52W High: ₹122.71
52W Low: ₹102.58
Annual Volatility: 22.63%
Check LEMONTREE Trade Fees →

Key Metrics Comparison Table

MetricMOREPENLABLEMONTREEEdge / Winner
Current Market Price (CMP) ₹129.55 ₹110.43 —
1-Year Price Return +213.76% -2.39% MOREPENLAB (216.15% higher)
52-Week High ₹146.97 ₹122.71 —
52-Week Low ₹41.29 ₹102.58 —
30-Day Annualized Volatility 72.31% 22.63% LEMONTREE (Steadier)
30-Day Average Daily Volume 21,356,220 3,940,246 MOREPENLAB (Higher Liquidity)
Statutory Cost to Trade ₹1 Lakh ₹118.50 ₹118.50 Identical statutory tariff

Frequently Asked Questions

Between MOREPENLAB and LEMONTREE, which stock gave better returns over the last year?

MOREPENLAB has outperformed LEMONTREE over the past 12 months with a gain of 213.76% compared to -2.39%.

Which stock is less volatile: MOREPENLAB or LEMONTREE?

LEMONTREE demonstrated lower price volatility (22.63% annualized) compared to MOREPENLAB (72.31%). Lower volatility generally indicates steadier price action during market downturns.

What is the statutory cost to buy ₹1,00,000 of MOREPENLAB vs LEMONTREE?

Statutory exchange and government charges (STT, NSE turnover fees, SEBI fee, Stamp duty, and GST) are identical for delivery purchases of equal rupee value across both stocks, totaling approximately ₹118.50 on discount brokers offering zero delivery brokerage (like Zerodha or Dhan).

Are MOREPENLAB and LEMONTREE direct sector competitors?

Yes, both companies operate within the Cross-Sector Peers sector in India and are actively tracked as sector peers by institutional and retail market participants.